Drug details

Jelmyto (mitomycin for pyelocalyceal solution)

type of Antineoplastics, Antibiotic

Jelmyto (mitomycin) is an alkylating drug used to treat adult patients with low-grade upper tract urothelial cancer (LG-UTUC).

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• fever,
• easy bruising,
• unusual bleeding,
• pale skin,
• cold hands and feet,
• chills,
• tiredness,
• mouth sores,
• skin sores,
• shortness of breath
• lightheadedness, and
• blood in your urine,
• pain or difficult urination,

The following drugs are related to Jelmyto, either as a replacement or used together:

• Adstiladrin (nadofaragene firadenovec-vncg suspension, for intravesical use)
• Imfinzi (durvalumab injection)
• Padcev (enfortumab vedotin-ejfv for injection)
• Fotivda (tivozanib capsules)
• Gemzar (gemcitabine hcl)
• Udenyca (pegfilgrastim-cbqv injection)
• Tepadina (thiotepa for injection)
• Valstar (valrubicin)